These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14677465)

  • 1. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
    Petri A; Dreyer L; Danneskiold-Samsøe B; Terslev L; Bliddal H
    Ugeskr Laeger; 2003 Nov; 165(48):4649-52. PubMed ID: 14677465
    [No Abstract]   [Full Text] [Related]  

  • 2. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
    J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 7. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
    Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
    Johnsen AK; Schiff MH; Mease PJ; Moreland LW; Maier AL; Coblyn JS; Helfgott SM; Leff JA; Weinblatt ME
    J Rheumatol; 2006 Apr; 33(4):659-64. PubMed ID: 16482646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab-associated multiple sclerosis.
    Bensouda-Grimaldi L; Mulleman D; Valat JP; Autret-Leca E
    J Rheumatol; 2007 Jan; 34(1):239-40; discussion 240. PubMed ID: 17216704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
    Wallenius M; Rødevand E; Skomsvoll JF
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1664-6. PubMed ID: 15976836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis.
    Kemp E; Nielsen H; Petersen LJ; Gam AN; Dahlager J; Horn T; Larsen S; Olsen S
    Clin Nephrol; 2001 Jan; 55(1):87-8. PubMed ID: 11200876
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic viral hepatitis and TNF-alpha blockade.
    Raftery G; Griffiths B; Kay L; Kane D
    Rheumatology (Oxford); 2007 Aug; 46(8):1381; author reply 1381-2. PubMed ID: 17567635
    [No Abstract]   [Full Text] [Related]  

  • 16. Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept).
    Sinha A; Patient C
    J Obstet Gynaecol; 2006 Oct; 26(7):689-91. PubMed ID: 17071443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etanercept for therapy of rheumatoid arthritis].
    Miyasaka N
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():521-5. PubMed ID: 15799411
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
    Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
    Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
    Carlson E; Rothfield N
    Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
    [No Abstract]   [Full Text] [Related]  

  • 20. Can tumor necrosis factor alpha blockade predispose to severe babesiosis?
    Taiwo B; Lee C; Venkat D; Tambar S; Sutton SH
    Arthritis Rheum; 2007 Feb; 57(1):179-81. PubMed ID: 17266091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.